SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2013 / Cilt: 10 - Sayı: 1

Four sisters affected by familial medullary thyroid cancer

Ailesel tiroid medüller karsinomlu dört kız kardeş

Cihad TATAR
Celal KIZILKAYA
Neslihan KURTULMUŞ
Rafet KAPLAN
Fazilet ERÖZGEN
Pages
21–23
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report here four sisters affected by FMTC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Familial Medullary Thyroid Cancer (FMTC) is a rare cancer of thyroid.
📊
Key Findings & Data:FMTC derived from parafollicular C cells and there is a known relationship between FMTC and RET protooncogene mutations.
💡
Conclusion & Impact:We report here four sisters affected by FMTC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Familial Medullary Thyroid Cancer (FMTC) is a rare cancer of thyroid. FMTC derived from parafollicular C cells and there is a known relationship between FMTC and RET protooncogene mutations. Genetic testing is considered the standard of care for all first-degree relatives of patients with newly diagnosed MTC and surgery should be performed. We report here four sisters affected by FMTC.

Özet

Ailesel medüller tiroid kanseri (FMTK) nadir görülen bir kanserdir. Parafoliküler C hücre hiperplazisi ve RET protoonkogeninin mutasyonu FMTKde rol oynamaktadır. Yeni FMTK tanısı alan hastaların 1. derece yakınlarına tarama yapılmalıdır ve bunlardan MTK tespit edilenlere cerrahi uygulanmalıdır. Çalışmamızda MTK tanısı konulmuş 4 kız kardeş ve bunların takipleri ile birlikte ailesel medüller tiroid karsinomu irdelenmiştir.

🔖

Cite This Article

TATAR, C., KIZILKAYA, C., KURTULMUŞ, N., KAPLAN, R., ERÖZGEN, F. (2022). Four sisters affected by familial medullary thyroid cancer. Endokrinolojide Diyalog Dergisi, Cilt: 10 - Sayı: 1, 21–23. https://ajindex.com/articles/500714

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Sayek İ, Karakoç D. Medüller Tiroid Kanseri. Sayek Temel Cerrahi, 4. baskı. 2013
  2. Wolfe HJ, DeLellis RA. Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab 1981;10:351– 365
  3. Perry A, Molberg K, Albores-Saavedra J. Physiologicversus neoplastic C-cell hyperplasia of the thyroid: separation of dis- tinct histologic and biologic entities. Cancer 1996;77:750–756 4. DeLellis RA, Lloyd RV, Heitz PU, et al. World health organiza- tion classification of 5. tumours. Pathology and genetics of tumours of endocrine organs. IARC Press: Lyon, 2004
  4. Fialkowski EA, Moley JF. Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol 2006;94:737–747
  5. Chiefari E, Russo D, Giuffrida D, et al. Analysis of RET proto- oncogene abnormalities in patients with MEN 2A, MEN 2B, fa- milial or sporadic medullary thyroid carcinoma. J Endocrinol Invest 1998;21:358–364.